Literature DB >> 23377344

The role of hypoxia in pulmonary vascular diseases: a perspective.

Norbert F Voelkel1, Shiro Mizuno, Harm J Bogaard.   

Abstract

From the discovery of hypoxic pulmonary vasoconstriction, responses to hypoxia have been considered as representative for the many alterations in lung vessels that occur in several chronic lung diseases, including pulmonary hypertension, interstitial pulmonary fibrosis, acute respiratory distress syndrome, and chronic obstructive pulmonary disease. An essential part of preclinical research to explain the pathobiology of these diseases has been centered on the exposure of small and large animals to hypoxia. This review aims to summarize pivotal results of clinical and preclinical research on hypoxia, which still have important implications for researchers today.

Entities:  

Mesh:

Year:  2013        PMID: 23377344     DOI: 10.1152/ajplung.00335.2012

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  19 in total

Review 1.  HIF and pulmonary vascular responses to hypoxia.

Authors:  Larissa A Shimoda; Steven S Laurie
Journal:  J Appl Physiol (1985)       Date:  2013-12-12

Review 2.  Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.

Authors:  Cyrus Kholdani; Wassim H Fares; Vahid Mohsenin
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

3.  Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia.

Authors:  David C Irwin; Chrystelle V Garat; Joseph T Crossno; Paul S MacLean; Timothy M Sullivan; Paul F Erickson; Matthew R Jackman; Julie W Harral; Jane E B Reusch; Dwight J Klemm
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

4.  Hypoxia increases the abundance but not the assembly of extracellular fibronectin during epithelial cell transdifferentiation.

Authors:  Manish K Rana; Jyoti Srivastava; Michael Yang; Christopher S Chen; Diane L Barber
Journal:  J Cell Sci       Date:  2015-01-22       Impact factor: 5.285

Review 5.  Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis.

Authors:  Richard Seonghun Nho
Journal:  Drug Dev Res       Date:  2015-08-25       Impact factor: 4.360

6.  Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis.

Authors:  Bradley A Maron; William M Oldham; Stephen Y Chan; Sara O Vargas; Elena Arons; Ying-Yi Zhang; Joseph Loscalzo; Jane A Leopold
Journal:  Circulation       Date:  2014-04-28       Impact factor: 29.690

7.  PLCγ1-PKCε-IP3R1 signaling plays an important role in hypoxia-induced calcium response in pulmonary artery smooth muscle cells.

Authors:  Vishal R Yadav; Tengyao Song; Lin Mei; Leroy Joseph; Yun-Min Zheng; Yong-Xiao Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-01       Impact factor: 5.464

Review 8.  The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Authors:  Steven C Pugliese; Jens M Poth; Mehdi A Fini; Andrea Olschewski; Karim C El Kasmi; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

9.  Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.

Authors:  Fei Sun; Guolun Wang; Arun Pradhan; Kui Xu; Jose Gomez-Arroyo; Yufang Zhang; Gregory T Kalin; Zicheng Deng; Ronald J Vagnozzi; Hua He; Andrew W Dunn; Yuhua Wang; Allen J York; Rashmi S Hegde; Jason C Woods; Tanya V Kalin; Jeffery D Molkentin; Vladimir V Kalinichenko
Journal:  Circulation       Date:  2021-06-11       Impact factor: 39.918

Review 10.  Pulmonary hypertension and right heart dysfunction in chronic lung disease.

Authors:  Amirmasoud Zangiabadi; Carmine G De Pasquale; Dimitar Sajkov
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.